Loading

Next-Gen Medicine: How Gene Editing and Epigenetics are Revolutionizing Health, Longevity, and Organ Transplantation

June 17, 2025
Breakout Session
Cell and Gene Therapy and Genome Editing
As gene editing and epigenetics evolve, they are not only transforming how we approach complex diseases but also unlocking new possibilities for enhancing longevity, healthspan, and even organ transplantation. These advancements offer the potential to treat conditions such as obesity, extend lifespan, and overcome organ shortages by developing genetically-engineered porcine organs. With these technologies moving beyond the lab, they hold promise for revolutionizing therapies and improving overall health, paving the way for longer, healthier lives and more effective treatments for a range of chronic conditions. This panel will explore the real-world applications of these groundbreaking technologies, highlighting their role in developing therapies for genetic disorders, obesity, age-related diseases, and organ transplantation. From CRISPR-based gene editing to innovative epigenetic strategies, speakers will discuss how these tools are being used to precisely regulate gene expression, target disease pathways, and create genetically engineered organs for transplantation.
Moderator
Uduak G.. Thomas, MA
Senior Editor
Genetic Engineering & Biotechnology News
Speakers
Elaine Cheung, MS
Chief Business Officer
Moonwalk Biosciences
Jim Martineau
CEO & Co-Founder
Nosis Bio
Daniel C. Oliver, MBA
CEO and Co-founder
Rejuvenate Bio
Wenning Qin, PhD
SVP Innovation
eGenesis

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS